VT
IBB icon

Vise Technologies’s iShares Biotechnology ETF IBB Stock Holding History

Vise Technologies’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$509K Hold
3,015
– – 0.01% 858
2025
Q4 		$509K Buy
+3,015
New +$490K 0.01% 863
2025
Q3 		– Sell
-2,754
Closed -$348K – 1206
2025
Q2 		$348K Buy
+2,754
New +$338K 0.01% 785
2024
Q4 		$339K Buy
2,568
+223
+10% +$31.4K 0.03% 549
2024
Q3 		$341K Sell
2,345
-170
-7% -$24.6K 0.04% 408
2024
Q2 		$345K Sell
2,515
-1,763
-41% -$235K 0.06% 288
2024
Q1 		$587K Buy
+4,278
New +$584K 0.12% 180

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vise Technologies's IBB Position: Q1 2026 in Review

Vise Technologies held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 3,015 shares worth $509K. The position accounts for 0.01% of the portfolio, ranked #858.

Vise Technologies first reported a position in IBB in Q1 2024 and has held it in 7 quarters since. The position peaked at $587K in Q1 2024. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Vise Technologies held 3,015 shares of iShares Biotechnology ETF worth $509K as of Q1 2026.
  • Vise Technologies left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.01% of Vise Technologies's portfolio in Q1 2026, its #858 holding.
  • Vise Technologies first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 7 quarters since.
  • Vise Technologies's iShares Biotechnology ETF position peaked at $587K in Q1 2024.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.